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Please note that an error appeared in the online early release version of this article. The fi  nal html, pdf, and print versions have been corrected. 
For reference, the correction appears below. 
The authors regret that an acknowledgment was left out of the fi  rst sentence of the Mice section under Materials and methods.  The sentence 
should have read: “TSAd (+/+) and (–/–) C57BL/6 mice were obtained from Dr. Jeff   Bluestone (University of California, San Francisco, San 
Francisco, CA) and were bred in our laboratory (4).”
Also, Fig. 2 contained a labeling error.  In panels A and B, all instances of “100” should have read “150.”  The corrected fi  gure and its legend 
appear below.
Figure 2.  Impaired LAT phosphorylation and interaction with PLCγ1 
and Grb-2 in TSAd-defi  cient T cells. LN T cells from TSAd (+/+) and 
(−/−) mice were stimulated with optimal concentrations of CD3 and CD28 
mAb for the indicated times (in min). (A) PLCγ1 activation was assessed by 
Western blotting of whole cell lysates using a phospho-specifi  c antibody. 
(B) LAT was immunoprecipitated from lysates. Phosphorylation of 
immunoprecipitated LAT on Y136 and Y195 and coimmunoprecipitation of 
PLCγ1 and Grb-2 was detected by Western blotting using specifi  c 
antibodies. (C) Activation of ZAP-70 was assessed by Western blotting of 
whole cell lysates using a phospho-specifi  c antibody.